Brexanolone (Zulresso): Finally, an FDA-Approved Treatment for Postpartum Depression

Powell, Jason; Garland, Scott; Preston, Kayla; Piszczatoski, Chris

doi:10.1177/1060028019873320

Public

Brexanolone (Zulresso): Finally, an FDA-Approved Treatment for Postpartum Depression

Published in Annals of Pharmacotherapy • Sep 3, 2019

Authors:

Jason Powell

Scott Garland

Kayla Preston

Abstract

Objective: To review the safety and efficacy of brexanolone for the treatment of moderate to severe postpartum depression (PPD). Data Sources: A literature search through PubMed was conducted (January 2012 to July 2019) using the keyword brexanolone for clinical trials published in the English langu...

Subject

Medicine

Food and drug administration

Depression (economics)

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!